Matt Eckler
Matt Eckler is a principal, Public Investing at Samsara BioCapital, which invests at seed, series a, series b in life sciences, with checks of $10M to $30M.
What Matt can write
Samsara BioCapital writes $10M to $30M checks, larger than 97% of firms in the atlas.
Bars: how many firms report each check band. Highlighted: Samsara BioCapital.Career
- RBC Capital Markets · investment role
- GMT Capital · investment role
- ArrowMark Partners · investment role
- RBC Capital Markets · Vice President and Senior Biotech Analyst
- Samsara BioCapital · PrincipalNow
Focus
Education
Also at Samsara BioCapital
Partners like Matt
At firms with a similar stage, sector and check size.
Alert me when Samsara BioCapital is active
One email when Matt's firm raises a fund, adds a partner or shows new activity.
Send Mode VC your deck
Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckQuestions
Who is Matt Eckler?
Matt Eckler is a principal, Public Investing at Samsara BioCapital, which invests at seed, series a, series b in life sciences, with checks of $10M to $30M.
How much does Matt Eckler invest?
Matt Eckler invests through Samsara BioCapital, which writes checks of $10M to $30M at seed, series a, series b.
How do I pitch Matt Eckler?
Email [email protected], the firm's inbox for founders, and name Matt in the subject. A warm intro from a founder Samsara BioCapital backed works better.
What did Matt Eckler do before Samsara BioCapital?
investment role at RBC Capital Markets; investment role at GMT Capital; investment role at ArrowMark Partners; Vice President and Senior Biotech Analyst at RBC Capital Markets.
Last updated 2026-10-15. Is this you? Ask for a correction.